Deborah C. Mash - Publications

Affiliations: 
University of Miami, Coral Gables, FL 
Area:
Neuroscience Biology, Pharmacology, Rehabilitation and Therapy

185 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any innacuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2016 Hammerschlag N, Davis DA, Mondo K, Seely MS, Murch SJ, Glover WB, Divoll T, Evers DC, Mash DC. Cyanobacterial Neurotoxin BMAA and Mercury in Sharks. Toxins. 8. PMID 27537913 DOI: 10.3390/toxins8080238  1
2016 Cox PA, Davis DA, Mash DC, Metcalf JS, Banack SA. Do vervets and macaques respond differently to BMAA? Neurotoxicology. PMID 27133441 DOI: 10.1016/j.neuro.2016.04.017  1
2016 Mash DC, Ameer B, Prou D, Howes JF, Maillet EL. Oral noribogaine shows high brain uptake and anti-withdrawal effects not associated with place preference in rodents. Journal of Psychopharmacology (Oxford, England). PMID 27044509 DOI: 10.1177/0269881116641331  1
2016 Cox PA, Davis DA, Mash DC, Metcalf JS, Banack SA. Dietary exposure to an environmental toxin triggers neurofibrillary tangles and amyloid deposits in the brain. Proceedings. Biological Sciences / the Royal Society. 283. PMID 26791617 DOI: 10.1098/rspb.2015.2397  1
2015 Webb A, Papp AC, Curtis A, Newman LC, Pietrzak M, Seweryn M, Handelman SK, Rempala GA, Wang D, Graziosa E, Tyndale RF, Lerman C, Kelsoe JR, Mash DC, Sadee W. RNA sequencing of transcriptomes in human brain regions: protein-coding and non-coding RNAs, isoforms and alleles. Bmc Genomics. 16: 990. PMID 26597164 DOI: 10.1186/s12864-015-2207-8  1
2015 Carithers LJ, Ardlie K, Barcus M, Branton PA, Britton A, Buia SA, Compton CC, DeLuca DS, Peter-Demchok J, Gelfand ET, Guan P, Korzeniewski GE, Lockhart NC, Rabiner CA, Rao AK, et al. A Novel Approach to High-Quality Postmortem Tissue Procurement: The GTEx Project. Biopreservation and Biobanking. 13: 311-9. PMID 26484571 DOI: 10.1089/bio.2015.0032  1
2015 Maillet EL, Milon N, Heghinian MD, Fishback J, Schürer SC, Garamszegi N, Mash DC. Noribogaine is a G-protein biased κ-opioid receptor agonist. Neuropharmacology. 99: 675-88. PMID 26302653 DOI: 10.1016/j.neuropharm.2015.08.032  1
2015 Lee CT, Freed WJ, Mash DC. CNVs in neurodevelopmental disorders. Oncotarget. 6: 18238-9. PMID 26285833  1
2015 Goldstein DS, Sullivan P, Holmes C, Kopin IJ, Sharabi Y, Mash DC. Decreased vesicular storage and aldehyde dehydrogenase activity in multiple system atrophy. Parkinsonism & Related Disorders. 21: 567-72. PMID 25829070 DOI: 10.1016/j.parkreldis.2015.03.006  1
2015 McAninch EA, Jo S, Preite NZ, Farkas E, Mohácsik P, Fekete C, Egri P, Gereben B, Li Y, Deng Y, Patti ME, Zevenbergen C, Peeters RP, Mash DC, Bianco AC. Prevalent polymorphism in thyroid hormone-activating enzyme leaves a genetic fingerprint that underlies associated clinical syndromes. The Journal of Clinical Endocrinology and Metabolism. 100: 920-33. PMID 25569702 DOI: 10.1210/jc.2014-4092  1
2015 Humphries CE, Kohli MA, Nathanson L, Whitehead P, Beecham G, Martin E, Mash DC, Pericak-Vance MA, Gilbert J. Integrated whole transcriptome and DNA methylation analysis identifies gene networks specific to late-onset Alzheimer's disease. Journal of Alzheimer's Disease : Jad. 44: 977-87. PMID 25380588 DOI: 10.3233/JAD-141989  1
2015 Kelly JA, Boyle NT, Cole N, Slator GR, Colivicchi MA, Stefanini C, Gobbo OL, Scalabrino GA, Ryan SM, Elamin M, Walsh C, Vajda A, Goggin MM, Campbell M, Mash DC, et al. First-in-class thyrotropin-releasing hormone (TRH)-based compound binds to a pharmacologically distinct TRH receptor subtype in human brain and is effective in neurodegenerative models. Neuropharmacology. 89: 193-203. PMID 25281210 DOI: 10.1016/j.neuropharm.2014.09.024  1
2015 Chang Q, Hanania T, Mash DC, Maillet EL. Noribogaine reduces nicotine self-administration in rats Journal of Psychopharmacology. 29: 704-711. DOI: 10.1177/0269881115584461  1
2015 Goldstein DS, Holmes C, Sullivan P, Mash DC, Sidransky E, Stefani A, Kopin IJ, Sharabi Y. Deficient vesicular storage: A common theme in catecholaminergic neurodegeneration Parkinsonism and Related Disorders. DOI: 10.1016/j.parkreldis.2015.07.009  1
2015 Humphries C, Kohli MA, Whitehead P, Mash DC, Pericak-Vance MA, Gilbert J. Alzheimer disease (AD) specific transcription, DNA methylation and splicing in twenty AD associated loci Molecular and Cellular Neuroscience. 67: 37-45. DOI: 10.1016/j.mcn.2015.05.003  1
2014 Enoch MA, Rosser AA, Zhou Z, Mash DC, Yuan Q, Goldman D. Expression of glutamatergic genes in healthy humans across 16 brain regions; altered expression in the hippocampus after chronic exposure to alcohol or cocaine. Genes, Brain, and Behavior. 13: 758-68. PMID 25262781 DOI: 10.1111/gbb.12179  1
2014 Beecham GW, Hamilton K, Naj AC, Martin ER, Huentelman M, Myers AJ, Corneveaux JJ, Hardy J, Vonsattel JP, Younkin SG, Bennett DA, De Jager PL, Larson EB, Crane PK, Kamboh MI, ... ... Mash DC, et al. Genome-wide association meta-analysis of neuropathologic features of Alzheimer's disease and related dementias. Plos Genetics. 10: e1004606. PMID 25188341 DOI: 10.1371/journal.pgen.1004606  1
2014 Glover WB, Mash DC, Murch SJ. The natural non-protein amino acid N-β-methylamino-L-alanine (BMAA) is incorporated into protein during synthesis. Amino Acids. 46: 2553-9. PMID 25096519 DOI: 10.1007/s00726-014-1812-1  1
2014 Mondo K, Broc Glover W, Murch SJ, Liu G, Cai Y, Davis DA, Mash DC. Environmental neurotoxins β-N-methylamino-l-alanine (BMAA) and mercury in shark cartilage dietary supplements. Food and Chemical Toxicology : An International Journal Published For the British Industrial Biological Research Association. 70: 26-32. PMID 24755394 DOI: 10.1016/j.fct.2014.04.015  1
2014 Chen GG, Diallo AB, Poujol R, Nagy C, Staffa A, Vaillancourt K, Lutz PE, Ota VK, Mash DC, Turecki G, Ernst C. BisQC: an operational pipeline for multiplexed bisulfite sequencing. Bmc Genomics. 15: 290. PMID 24734894 DOI: 10.1186/1471-2164-15-290  1
2014 de Rivero Vaccari JP, Brand FJ, Sedaghat C, Mash DC, Dietrich WD, Keane RW. RIG-1 receptor expression in the pathology of Alzheimer's disease. Journal of Neuroinflammation. 11: 67. PMID 24694234 DOI: 10.1186/1742-2094-11-67  1
2014 Nuytemans K, Inchausti V, Beecham GW, Wang L, Dickson DW, Trojanowski JQ, Lee VM, Mash DC, Frosch MP, Foroud TM, Honig LS, Montine TJ, Dawson TM, Martin ER, Scott WK, et al. Absence of C9ORF72 expanded or intermediate repeats in autopsy-confirmed Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society. 29: 827-30. PMID 24573903 DOI: 10.1002/mds.25838  1
2013 Mash DC. Commentary on: Johnson MM, David JA, Michelhaugh SK, Schmidt CJ, Bannon MJ. Increased heat shock protein 70 gene expression in the brains of cocaine-related fatalities may be reflective of postdrug survival and intervention rather than excited delirium. J Forensic Sci 2012;57(6):1519-23. Journal of Forensic Sciences. 58: 559-61. PMID 24811527 DOI: 10.1111/1556-4029.12081  1
2013 Williams SL, Mash DC, Züchner S, Moraes CT. Somatic mtDNA mutation spectra in the aging human putamen. Plos Genetics. 9: e1003990. PMID 24339796 DOI: 10.1371/journal.pgen.1003990  1
2013 Duka V, Lee JH, Credle J, Wills J, Oaks A, Smolinsky C, Shah K, Mash DC, Masliah E, Sidhu A. Identification of the sites of tau hyperphosphorylation and activation of tau kinases in synucleinopathies and Alzheimer's diseases. Plos One. 8: e75025. PMID 24073234 DOI: 10.1371/journal.pone.0075025  1
2013 Xie X, Basile M, Mash DC. Cerebral uptake and protein incorporation of cyanobacterial toxin β-N-methylamino-L-alanine. Neuroreport. 24: 779-84. PMID 23979257 DOI: 10.1097/WNR.0b013e328363fd89  1
2013 Goldstein DS, Sullivan P, Holmes C, Miller GW, Alter S, Strong R, Mash DC, Kopin IJ, Sharabi Y. Determinants of buildup of the toxic dopamine metabolite DOPAL in Parkinson's disease. Journal of Neurochemistry. 126: 591-603. PMID 23786406 DOI: 10.1111/jnc.12345  1
2013 Spalding KL, Bergmann O, Alkass K, Bernard S, Salehpour M, Huttner HB, Boström E, Westerlund I, Vial C, Buchholz BA, Possnert G, Mash DC, Druid H, Frisén J. Dynamics of hippocampal neurogenesis in adult humans. Cell. 153: 1219-27. PMID 23746839 DOI: 10.1016/j.cell.2013.05.002  1
2013 Boeve BF, Silber MH, Ferman TJ, Lin SC, Benarroch EE, Schmeichel AM, Ahlskog JE, Caselli RJ, Jacobson S, Sabbagh M, Adler C, Woodruff B, Beach TG, Iranzo A, Gelpi E, ... ... Mash DC, et al. Clinicopathologic correlations in 172 cases of rapid eye movement sleep behavior disorder with or without a coexisting neurologic disorder. Sleep Medicine. 14: 754-62. PMID 23474058 DOI: 10.1016/j.sleep.2012.10.015  1
2013 Sullivan D, Pinsonneault JK, Papp AC, Zhu H, Lemeshow S, Mash DC, Sadee W. Dopamine transporter DAT and receptor DRD2 variants affect risk of lethal cocaine abuse: a gene-gene-environment interaction. Translational Psychiatry. 3: e222. PMID 23340505 DOI: 10.1038/tp.2012.146  1
2012 Yuan Q, Zhou Z, Lindell SG, Higley JD, Ferguson B, Thompson RC, Lopez JF, Suomi SJ, Baghal B, Baker M, Mash DC, Barr CS, Goldman D. The rhesus macaque is three times as diverse but more closely equivalent in damaging coding variation as compared to the human. Bmc Genetics. 13: 52. PMID 22747632 DOI: 10.1186/1471-2156-13-52  1
2012 Mondo K, Hammerschlag N, Basile M, Pablo J, Banack SA, Mash DC. Cyanobacterial neurotoxin β-N-methylamino-L-alanine (BMAA) in shark fins. Marine Drugs. 10: 509-20. PMID 22412816 DOI: 10.3390/md10020509  1
2012 Wider C, Ross OA, Nishioka K, Heckman MG, Vilariño-Güell C, Jasinska-Myga B, Erketin-Taner N, Rademakers R, Graff-Radford NR, Mash DC, Papapetropoulos S, Duara R, Uchikado H, Wszolek ZK, Farrer MJ, et al. An evaluation of the impact of MAPT, SNCA and APOE on the burden of Alzheimer's and Lewy body pathology. Journal of Neurology, Neurosurgery, and Psychiatry. 83: 424-9. PMID 22291217 DOI: 10.1136/jnnp-2011-301413  1
2012 Enoch MA, Zhou Z, Kimura M, Mash DC, Yuan Q, Goldman D. GABAergic gene expression in postmortem hippocampus from alcoholics and cocaine addicts; corresponding findings in alcohol-naïve P and NP rats. Plos One. 7: e29369. PMID 22253714 DOI: 10.1371/journal.pone.0029369  1
2012 Mann A, Miksys SL, Gaedigk A, Kish SJ, Mash DC, Tyndale RF. The neuroprotective enzyme CYP2D6 increases in the brain with age and is lower in Parkinson's disease patients. Neurobiology of Aging. 33: 2160-71. PMID 21958961 DOI: 10.1016/j.neurobiolaging.2011.08.014  1
2012 Vilke GM, DeBard ML, Chan TC, Ho JD, Dawes DM, Hall C, Curtis MD, Costello MW, Mash DC, Coffman SR, McMullen MJ, Metzger JC, Roberts JR, Sztajnkrcer MD, Henderson SO, et al. Excited Delirium Syndrome (ExDS): defining based on a review of the literature. The Journal of Emergency Medicine. 43: 897-905. PMID 21440403 DOI: 10.1016/j.jemermed.2011.02.017  1
2011 Zhou Z, Yuan Q, Mash DC, Goldman D. Substance-specific and shared transcription and epigenetic changes in the human hippocampus chronically exposed to cocaine and alcohol. Proceedings of the National Academy of Sciences of the United States of America. 108: 6626-31. PMID 21464311 DOI: 10.1073/pnas.1018514108  1
2011 Edwards YJ, Beecham GW, Scott WK, Khuri S, Bademci G, Tekin D, Martin ER, Jiang Z, Mash DC, ffrench-Mullen J, Pericak-Vance MA, Tsinoremas N, Vance JM. Identifying consensus disease pathways in Parkinson's disease using an integrative systems biology approach. Plos One. 6: e16917. PMID 21364952 DOI: 10.1371/journal.pone.0016917  1
2011 Vilariño-Güell C, Soto-Ortolaza AI, Rajput A, Mash DC, Papapetropoulos S, Pahwa R, Lyons KE, Uitti RJ, Wszolek ZK, Dickson DW, Farrer MJ, Ross OA. MAPT H1 haplotype is a risk factor for essential tremor and multiple system atrophy. Neurology. 76: 670-2. PMID 21321341 DOI: 10.1212/WNL.0b013e31820c30c1  1
2011 Moyer RA, Wang D, Papp AC, Smith RM, Duque L, Mash DC, Sadee W. Intronic polymorphisms affecting alternative splicing of human dopamine D2 receptor are associated with cocaine abuse. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 36: 753-62. PMID 21150907 DOI: 10.1038/npp.2010.208  1
2011 Goldstein DS, Sullivan P, Holmes C, Kopin IJ, Basile MJ, Mash DC. Catechols in post-mortem brain of patients with Parkinson disease. European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies. 18: 703-10. PMID 21073636 DOI: 10.1111/j.1468-1331.2010.03246.x  1
2011 Nishioka K, Ross OA, Vilariño-Güell C, Cobb SA, Kachergus JM, Mann DM, Snowden J, Richardson AM, Neary D, Robinson CA, Rajput A, Papapetropoulos S, Mash DC, Pahwa R, Lyons KE, et al. Glucocerebrosidase mutations in diffuse Lewy body disease. Parkinsonism & Related Disorders. 17: 55-7. PMID 20971030 DOI: 10.1016/j.parkreldis.2010.09.009  1
2011 Smith RM, Alachkar H, Papp AC, Wang D, Mash DC, Wang JC, Bierut LJ, Sadee W. Nicotinic α5 receptor subunit mRNA expression is associated with distant 5' upstream polymorphisms. European Journal of Human Genetics : Ejhg. 19: 76-83. PMID 20700147 DOI: 10.1038/ejhg.2010.120  1
2010 Brand LE, Pablo J, Compton A, Hammerschlag N, Mash DC. Cyanobacterial Blooms and the Occurrence of the neurotoxin beta-N-methylamino-L-alanine (BMAA) in South Florida Aquatic Food Webs. Harmful Algae. 9: 620-635. PMID 21057660 DOI: 10.1016/j.hal.2010.05.002  1
2010 Adi N, Mash DC, Ali Y, Singer C, Shehadeh L, Papapetropoulos S. Melatonin MT1 and MT2 receptor expression in Parkinson's disease. Medical Science Monitor : International Medical Journal of Experimental and Clinical Research. 16: BR61-7. PMID 20110911  1
2010 Mash DC. Ibogaine therapy for substance abuse disorders Clinical Addiction Psychiatry. 50-60. DOI: 10.1017/CBO9780511782107.007  1
2009 Bradley WG, Mash DC. Beyond Guam: the cyanobacteria/BMAA hypothesis of the cause of ALS and other neurodegenerative diseases. Amyotrophic Lateral Sclerosis : Official Publication of the World Federation of Neurology Research Group On Motor Neuron Diseases. 10: 7-20. PMID 19929726 DOI: 10.3109/17482960903286009  1
2009 Mash DC, Duque L, Pablo J, Qin Y, Adi N, Hearn WL, Hyma BA, Karch SB, Druid H, Wetli CV. Brain biomarkers for identifying excited delirium as a cause of sudden death. Forensic Science International. 190: e13-9. PMID 19541436 DOI: 10.1016/j.forsciint.2009.05.012  1
2009 Pablo J, Banack SA, Cox PA, Johnson TE, Papapetropoulos S, Bradley WG, Buck A, Mash DC. Cyanobacterial neurotoxin BMAA in ALS and Alzheimer's disease. Acta Neurologica Scandinavica. 120: 216-25. PMID 19254284 DOI: 10.1111/j.1600-0404.2008.01150.x  1
2009 Vilariño-Güell C, Soto AI, Lincoln SJ, Ben Yahmed S, Kefi M, Heckman MG, Hulihan MM, Chai H, Diehl NN, Amouri R, Rajput A, Mash DC, Dickson DW, Middleton LT, Gibson RA, et al. ATP13A2 variability in Parkinson disease. Human Mutation. 30: 406-10. PMID 19085912 DOI: 10.1002/humu.20877  1
2009 Jiang X, Zhou J, Mash DC, Marini AM, Lipsky RH. Human BDNF isoforms are differentially expressed in cocaine addicts and are sorted to the regulated secretory pathway independent of the Met66 substitution. Neuromolecular Medicine. 11: 1-12. PMID 18946637 DOI: 10.1007/s12017-008-8051-0  1
2009 Farrer MJ, Williams LN, Algom AA, Kachergus J, Hulihan MM, Ross OA, Rajput A, Papapetropoulos S, Mash DC, Dickson DW. Glucosidase-beta variations and Lewy body disorders. Parkinsonism & Related Disorders. 15: 414-6. PMID 18829375 DOI: 10.1016/j.parkreldis.2008.08.004  1
2009 Zhou Z, Zhu G, Hariri AR, Enoch MA, Scott D, Sinha R, Virkkunen M, Mash DC, Lipsky RH, Hu XZ, Hodgkinson CA, Xu K, Buzas B, Yuan Q, Shen PH, et al. Zhou et al. reply Nature. 458: E7. DOI: 10.1038/nature07928  1
2009 Mash DC. Biochemical brain markers in excited delirium deaths Taser® Conducted Electrical Weapons: Physiology, Pathology, and Law. 365-377. DOI: 10.1007/978-0-387-85475-5_29  1
2008 Lull ME, Freeman WM, Vrana KE, Mash DC. Correlating human and animal studies of cocaine abuse and gene expression. Annals of the New York Academy of Sciences. 1141: 58-75. PMID 18991951 DOI: 10.1196/annals.1441.013  1
2008 Mann A, Miksys S, Lee A, Mash DC, Tyndale RF. Induction of the drug metabolizing enzyme CYP2D in monkey brain by chronic nicotine treatment. Neuropharmacology. 55: 1147-55. PMID 18687346 DOI: 10.1016/j.neuropharm.2008.07.017  1
2008 Zhou Z, Zhu G, Hariri AR, Enoch MA, Scott D, Sinha R, Virkkunen M, Mash DC, Lipsky RH, Hu XZ, Hodgkinson CA, Xu K, Buzas B, Yuan Q, Shen PH, et al. Genetic variation in human NPY expression affects stress response and emotion. Nature. 452: 997-1001. PMID 18385673 DOI: 10.1038/nature06858  1
2008 Mash DC, Adi N, Duque L, Pablo J, Kumar M, Ervin FR. Alpha synuclein protein levels are increased in serum from recently abstinent cocaine abusers. Drug and Alcohol Dependence. 94: 246-50. PMID 18055133 DOI: 10.1016/j.drugalcdep.2007.09.020  1
2008 Mash DC. Cyanobacterial toxins in neurodegeneration Continuum Lifelong Learning in Neurology. 14: 138-149. DOI: 10.1212/01.CON.0000337997.85667.1f  1
2007 Schenk S, Hely L, Lake B, Daniela E, Gittings D, Mash DC. MDMA self-administration in rats: acquisition, progressive ratio responding and serotonin transporter binding. The European Journal of Neuroscience. 26: 3229-36. PMID 18005064 DOI: 10.1111/j.1460-9568.2007.05932.x  1
2007 Mash DC, ffrench-Mullen J, Adi N, Qin Y, Buck A, Pablo J. Gene expression in human hippocampus from cocaine abusers identifies genes which regulate extracellular matrix remodeling. Plos One. 2: e1187. PMID 18000554 DOI: 10.1371/journal.pone.0001187  1
2007 Lesnick TG, Papapetropoulos S, Mash DC, Ffrench-Mullen J, Shehadeh L, de Andrade M, Henley JR, Rocca WA, Ahlskog JE, Maraganore DM. A genomic pathway approach to a complex disease: axon guidance and Parkinson disease. Plos Genetics. 3: e98. PMID 17571925 DOI: 10.1371/journal.pgen.0030098  1
2007 Papapetropoulos S, Adi N, Mash DC, Shehadeh L, Bishopric N, Shehadeh L. Expression of alpha-synuclein mRNA in Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society. 22: 1057-9; author reply. PMID 17373725 DOI: 10.1002/mds.21466  1
2007 Papapetropoulos S, Tuchman A, Laufer D, Papatsoris AG, Papapetropoulos N, Mash DC. Causes of death in multiple system atrophy. Journal of Neurology, Neurosurgery, and Psychiatry. 78: 327-9. PMID 17308296 DOI: 10.1136/jnnp.2006.103929  1
2007 Lincoln SJ, Ross OA, Milkovic NM, Dickson DW, Rajput A, Robinson CA, Papapetropoulos S, Mash DC, Farrer MJ. Quantitative PCR-based screening of alpha-synuclein multiplication in multiple system atrophy. Parkinsonism & Related Disorders. 13: 340-2. PMID 17291816 DOI: 10.1016/j.parkreldis.2006.12.005  1
2007 Papapetropoulos S, Farrer MJ, Stone JT, Milkovic NM, Ross OA, Calvo L, McQuorquodale D, Mash DC. Phenotypic associations of tau and ApoE in Parkinson's disease. Neuroscience Letters. 414: 141-4. PMID 17204369 DOI: 10.1016/j.neulet.2006.12.008  1
2007 Papapetropoulos S, Mash DC. Motor fluctuations and dyskinesias in advanced/end stage Parkinson's disease: A study from a population of brain donors Journal of Neural Transmission. 114: 341-345. PMID 17146589 DOI: 10.1007/s00702-006-0603-6  1
2007 Papapetropoulos S, Basel M, Mash DC. Dopaminergic innervation of the human striatum in Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society. 22: 286-8. PMID 17083095 DOI: 10.1002/mds.21196  1
2007 Tannu N, Mash DC, Hemby SE. Cytosolic proteomic alterations in the nucleus accumbens of cocaine overdose victims. Molecular Psychiatry. 12: 55-73. PMID 17075605 DOI: 10.1038/sj.mp.4001914  1
2007 Papapetropoulos S, Tuchman A, Laufer D, Mash DC. Hallucinations in multiple system atrophy. Parkinsonism & Related Disorders. 13: 193-4. PMID 17049296 DOI: 10.1016/j.parkreldis.2006.07.016  1
2007 Grudzien A, Shaw P, Weintraub S, Bigio E, Mash DC, Mesulam MM. Locus coeruleus neurofibrillary degeneration in aging, mild cognitive impairment and early Alzheimer's disease. Neurobiology of Aging. 28: 327-35. PMID 16574280 DOI: 10.1016/j.neurobiolaging.2006.02.007  1
2006 Papapetropoulos S, Ffrench-Mullen J, McCorquodale D, Qin Y, Pablo J, Mash DC. Multiregional gene expression profiling identifies MRPS6 as a possible candidate gene for Parkinson's disease. Gene Expression. 13: 205-15. PMID 17193926 DOI: 10.3727/000000006783991827  1
2006 Papapetropoulos S, Singer C, Ross OA, Toft M, Johnson JL, Farrer MJ, Mash DC. Clinical heterogeneity of the LRRK2 G2019S mutation. Archives of Neurology. 63: 1242-6. PMID 16966501 DOI: 10.1001/archneur.63.9.1242  1
2006 Passarella D, Barilli A, Efange SMN, Elisabetsky E, Leal MB, Lesma G, Linck VM, Mash DC, Martinelli M, Peretto I, Silvani A, Danieli B. Nature-inspired indolyl-2-azabicyclo[2.2.2]oct-7-ene derivatives as promising agents for the attenuation of withdrawal symptoms: Synthesis of 20-desethyl-20-hydroxymethyl-11-demethoxyibogaine Natural Product Research. 20: 758-765. PMID 16753910 DOI: 10.1080/14786410500160645  1
2006 Drgon T, Lin Z, Wang GJ, Fowler J, Pablo J, Mash DC, Volkow N, Uhl GR. Common human 5' dopamine transporter (SLC6A3) haplotypes yield varying expression levels in vivo. Cellular and Molecular Neurobiology. 26: 875-89. PMID 16710758 DOI: 10.1007/s10571-006-9014-3  1
2006 Papapetropoulos S, Villar JM, Mash DC. Is ischemic cerebrovascular disease a risk factor for dementia in patients with Parkinson's disease? [1] Acta Neurologica Scandinavica. 113: 353-354. PMID 16629774 DOI: 10.1111/j.1600-0404.2006.00582.x  1
2006 Papapetropoulos S, Villar JM, Gonzalez J, Mash DC. Disparities in death certificates of Parkinson's disease patients: a report from a population of brain donors. Movement Disorders : Official Journal of the Movement Disorder Society. 21: 1791-2; author reply. PMID 16544292 DOI: 10.1002/mds.20832  1
2006 Papapetropoulos S, Lieberman A, Gonzalez J, Singer C, Laufer DZ, Mash DC. Family history of dementia: dementia with lewy bodies and dementia in Parkinson's disease. The Journal of Neuropsychiatry and Clinical Neurosciences. 18: 113-6. PMID 16525079 DOI: 10.1176/jnp.18.1.113  1
2006 Ross OA, Toft M, Whittle AJ, Johnson JL, Papapetropoulos S, Mash DC, Litvan I, Gordon MF, Wszolek ZK, Farrer MJ, Dickson DW. Lrrk2 and Lewy body disease. Annals of Neurology. 59: 388-93. PMID 16437559 DOI: 10.1002/ana.20731  1
2006 Papapetropoulos S, Gonzalez J, Mash DC. The effect of ischemic cerebrovascular disease on the clinical characteristics of Parkinson's disease. A post-mortem study [4] European Journal of Neurology. 13: 96-97. PMID 16420403 DOI: 10.1111/j.1468-1331.2006.01092.x  1
2006 Papapetropoulos S, McCorquodale DS, Gonzalez J, Jean-Gilles L, Mash DC. Cortical and amygdalar Lewy body burden in Parkinson's disease patients with visual hallucinations. Parkinsonism & Related Disorders. 12: 253-6. PMID 16368258 DOI: 10.1016/j.parkreldis.2005.10.005  1
2005 Papapetropoulos S, Mash DC. Visual hallucinations in progressive supranuclear palsy. European Neurology. 54: 217-9. PMID 16401896 DOI: 10.1159/000090713  1
2005 Hemby SE, Tang W, Muly EC, Kuhar MJ, Howell L, Mash DC. Cocaine-induced alterations in nucleus accumbens ionotropic glutamate receptor subunits in human and non-human primates. Journal of Neurochemistry. 95: 1785-93. PMID 16363995 DOI: 10.1111/j.1471-4159.2005.03517.x  1
2005 Papapetropoulos S, Singer C, McCorquodale D, Gonzalez J, Mash DC. Cause, seasonality of death and co-morbidities in progressive supranuclear palsy (PSP). Parkinsonism & Related Disorders. 11: 459-63. PMID 16154793 DOI: 10.1016/j.parkreldis.2005.06.003  1
2005 Qin Y, Ouyang Q, Pablo J, Mash DC. Cocaine abuse elevates alpha-synuclein and dopamine transporter levels in the human striatum. Neuroreport. 16: 1489-93. PMID 16110277 DOI: 10.1097/01.wnr.0000175617.39054.ba  1
2005 Papapetropoulos S, Gonzalez J, Mash DC. Natural history of progressive supranuclear palsy: a clinicopathologic study from a population of brain donors. European Neurology. 54: 1-9. PMID 16015014 DOI: 10.1159/000086754  1
2005 Papapetropoulos S, Mash DC. Psychotic symptoms in Parkinson's disease: From description to etiology Journal of Neurology. 252: 753-764. PMID 15999234 DOI: 10.1007/s00415-005-0918-5  1
2005 Papapetropoulos S, Lieberman A, Gonzalez J, Mash DC. Can Alzheimer's type pathology influence the clinical phenotype of Parkinson's disease? Acta Neurologica Scandinavica. 111: 353-359. PMID 15876335 DOI: 10.1111/j.1600-0404.2005.00411.x  1
2005 Papapetropoulos S, Gonzalez J, Lieberman A, Villar JM, Mash DC. Dementia in Parkinson's disease: A post-mortem study in a population of brain donors International Journal of Geriatric Psychiatry. 20: 418-422. PMID 15852454 DOI: 10.1002/gps.1297  1
2005 Papapetropoulos S, Mash DC. Alpha-synuclein aggregation and its relation to neurodegenerative diseases. Annals of Neurology. 57: 605; author reply 60. PMID 15786478 DOI: 10.1002/ana.20414  1
2005 Mash DC, Ouyang Q, Qin Y, Pablo J. Norepinephrine transporter immunoblotting and radioligand binding in cocaine abusers. Journal of Neuroscience Methods. 143: 79-85. PMID 15763139 DOI: 10.1016/j.jneumeth.2004.09.013  1
2005 Papapetropoulos S, Mash DC. The neurochemical mechanism of rebound psychosis in Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society. 20: 515; author reply 51. PMID 15747367 DOI: 10.1002/mds.20438  1
2005 Papapetropoulos S, Singer C, Villar JM, Gonzalez J, Mash DC. Does cigarette smoking provide clinically significant neuroprotection among patients diagnosed with Parkinson's disease? Movement Disorders : Official Journal of the Movement Disorder Society. 20: 641-2. PMID 15747366 DOI: 10.1002/mds.20433  1
2005 Rossi MA, Mash DC, deToledo-Morrell L. Spatial memory in aged rats is related to PKCgamma-dependent G-protein coupling of the M1 receptor. Neurobiology of Aging. 26: 53-68. PMID 15585346 DOI: 10.1016/j.neurobiolaging.2004.02.029  1
2004 Zhu G, Lipsky RH, Xu K, Ali S, Hyde T, Kleinman J, Akhtar LA, Mash DC, Goldman D. Differential expression of human COMT alleles in brain and lymphoblasts detected by RT-coupled 5' nuclease assay. Psychopharmacology. 177: 178-84. PMID 15290009 DOI: 10.1007/s00213-004-1938-z  1
2004 Stephens BG, Jentzen JM, Karch S, Wetli CV, Mash DC. National Association of Medical Examiners position paper on the certification of cocaine-related deaths. The American Journal of Forensic Medicine and Pathology. 25: 11-3. PMID 15075681 DOI: 10.1097/01.paf.0000114041.70865.24  1
2004 Stephens BG, Jentzen JM, Karch S, Mash DC, Wetli CV. Criteria for the interpretation of cocaine levels in human biological samples and their relation to the cause of death. The American Journal of Forensic Medicine and Pathology. 25: 1-10. PMID 15075680 DOI: 10.1097/01.paf.0000118960.58334.a9  1
2004 Lockhart PJ, Lincoln S, Hulihan M, Kachergus J, Wilkes K, Bisceglio G, Mash DC, Farrer MJ. DJ-1 mutations are a rare cause of recessively inherited early onset parkinsonism mediated by loss of protein function. Journal of Medical Genetics. 41: e22. PMID 14985393  1
2003 Hurley MJ, Mash DC, Jenner P. Expression of cannabinoid CB1 receptor mRNA in basal ganglia of normal and parkinsonian human brain Journal of Neural Transmission. 110: 1279-1288. PMID 14628192 DOI: 10.1007/s00702-003-0033-7  1
2003 Hurley MJ, Mash DC, Jenner P. Markers for dopaminergic neurotransmission in the cerebellum in normal individuals and patients with Parkinson's disease examined by RT-PCR. The European Journal of Neuroscience. 18: 2668-72. PMID 14622169 DOI: 10.1046/j.1460-9568.2003.02963.x  1
2003 Miksys S, Lerman C, Shields PG, Mash DC, Tyndale RF. Smoking, alcoholism and genetic polymorphisms alter CYP2B6 levels in human brain. Neuropharmacology. 45: 122-32. PMID 12814665 DOI: 10.1016/S0028-3908(03)00136-9  1
2003 Guillozet AL, Weintraub S, Mash DC, Mesulam MM. Neurofibrillary tangles, amyloid, and memory in aging and mild cognitive impairment. Archives of Neurology. 60: 729-36. PMID 12756137 DOI: 10.1001/archneur.60.5.729  1
2003 Tang WX, Fasulo WH, Mash DC, Hemby SE. Molecular profiling of midbrain dopamine regions in cocaine overdose victims. Journal of Neurochemistry. 85: 911-24. PMID 12716423  1
2003 Mash DC, Ouyang Q, Pablo J, Basile M, Izenwasser S, Lieberman A, Perrin RJ. Cocaine abusers have an overexpression of alpha-synuclein in dopamine neurons. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 23: 2564-71. PMID 12684441  1
2003 Passarella D, Favia R, Giardini A, Lesma G, Martinelli M, Silvani A, Danieli B, Efange SM, Mash DC. Ibogaine analogues. Synthesis and preliminary pharmacological evaluation of 7-heteroaryl-2-azabicyclo[2.2.2]oct-7-enes. Bioorganic & Medicinal Chemistry. 11: 1007-14. PMID 12614886 DOI: 10.1016/S0968-0896(02)00524-2  1
2002 Henderson RF, Barr EB, Blackwell WB, Clark CR, Conn CA, Kalra R, March TH, Sopori ML, Tesfaigzi Y, Ménache MG, Mash DC. Response of rats to low levels of sarin. Toxicology and Applied Pharmacology. 184: 67-76. PMID 12408950 DOI: 10.1016/S0041-008X(02)99495-0  1
2002 Miksys S, Rao Y, Hoffmann E, Mash DC, Tyndale RF. Regional and cellular expression of CYP2D6 in human brain: higher levels in alcoholics. Journal of Neurochemistry. 82: 1376-87. PMID 12354285 DOI: 10.1046/j.1471-4159.2002.01069.x  1
2002 Pérez S, Basile M, Mash DC, Mufson EJ. Galanin receptor over-expression within the amygdala in early Alzheimer's disease: an in vitro autoradiographic analysis. Journal of Chemical Neuroanatomy. 24: 109-16. PMID 12191727 DOI: 10.1016/S0891-0618(02)00034-0  1
2002 Mash DC, Pablo J, Ouyang Q, Hearn WL, Izenwasser S. Dopamine transport function is elevated in cocaine users. Journal of Neurochemistry. 81: 292-300. PMID 12064476 DOI: 10.1046/j.1471-4159.2002.00820.x  1
2002 Bannon MJ, Pruetz B, Manning-Bog AB, Whitty CJ, Michelhaugh SK, Sacchetti P, Granneman JG, Mash DC, Schmidt CJ. Decreased expression of the transcription factor NURR1 in dopamine neurons of cocaine abusers. Proceedings of the National Academy of Sciences of the United States of America. 99: 6382-5. PMID 11959923 DOI: 10.1073/pnas.092654299  1
2001 Henderson RF, Barr EB, Blackwell WB, Clark CR, Conn CA, Kalra R, March TH, Sopori ML, Tesfaigzi Y, Ménache MG, Mash DC, Dokladny K, Kozak W, Kozak A, Wachulec M, et al. Response of F344 rats to inhalation of subclinical levels of sarin: Exploring potential causes of Gulf War illness Toxicology and Industrial Health. 17: 294-297. PMID 12539875  1
2001 Counts SE, Perez SE, Kahl U, Bartfai T, Bowser RP, Deecher DC, Mash DC, Crawley JN, Mufson EJ. Galanin: neurobiologic mechanisms and therapeutic potential for Alzheimer's disease. Cns Drug Reviews. 7: 445-70. PMID 11830760  1
2001 Baumann MH, Pablo J, Ali SF, Rothman RB, Mash DC. Chapter 5 Comparative neuropharmacology of ibogaine and its O-desmethyl metabolite, noribogaine Alkaloids: Chemistry and Biology. 56: 79-113. PMID 11705118  1
2001 Mash DC, Kovera CA, Pablo J, Tyndale R, Ervin FR, Kamlet JD, Hearn WL. Ibogaine in the treatment of heroin withdrawal. The Alkaloids. Chemistry and Biology. 56: 155-71. PMID 11705106  1
2001 Baumann MH, Rothman RB, Pablo JP, Mash DC. In vivo neurobiological effects of ibogaine and its O-desmethyl metabolite, 12-hydroxyibogamine (noribogaine), in rats. The Journal of Pharmacology and Experimental Therapeutics. 297: 531-9. PMID 11303040  1
2001 Hurley MJ, Mash DC, Jenner P. Dopamine D1 receptor expression in human basal ganglia and changes in Parkinson's disease Molecular Brain Research. 87: 271-279. PMID 11245931 DOI: 10.1016/S0169-328X(01)00022-5  1
2001 Eshleman AJ, Wolfrum K, Mash DC, Christensen K, Janowsky A. Drug interactions with the dopamine transporter in cryopreserved human caudate. The Journal of Pharmacology and Experimental Therapeutics. 296: 442-9. PMID 11160629  1
2000 Mash DC, Staley JK, Izenwasser S, Basile M, Ruttenber AJ. Serotonin transporters upregulate with chronic cocaine use. Journal of Chemical Neuroanatomy. 20: 271-80. PMID 11207425 DOI: 10.1016/S0891-0618(00)00102-2  1
2000 Mash DC, Kovera CA, Pablo J, Tyndale RF, Ervin FD, Williams IC, Singleton EG, Mayor M. Ibogaine: complex pharmacokinetics, concerns for safety, and preliminary efficacy measures. Annals of the New York Academy of Sciences. 914: 394-401. PMID 11085338  1
2000 Baumann MH, Pablo JP, Ali SF, Rothman RB, Mash DC. Noribogaine (12-hydroxyibogamine): a biologically active metabolite of the antiaddictive drug ibogaine. Annals of the New York Academy of Sciences. 914: 354-68. PMID 11085335  1
2000 Wang Y, TesFaye E, Yasuda RP, Mash DC, Armstrong DM, Wolfe BB. Effects of post-mortem delay on subunits of ionotropic glutamate receptors in human brain. Brain Research. Molecular Brain Research. 80: 123-31. PMID 11038245 DOI: 10.1016/S0169-328X(00)00111-X  1
2000 Hurley MJ, Mash DC, Jenner P. Adenosine A(2A) receptor mRNA expression in Parkinson's disease Neuroscience Letters. 291: 54-58. PMID 10962152 DOI: 10.1016/S0304-3940(00)01371-9  1
2000 Mufson EJ, Deecher DC, Basile M, Izenwasse S, Mash DC. Galanin receptor plasticity within the nucleus basalis in early and late Alzheimer's disease: an in vitro autoradiographic analysis. Neuropharmacology. 39: 1404-12. PMID 10818256 DOI: 10.1016/S0028-3908(00)00011-3  1
1999 Chen L, Segal DM, Moraes CT, Mash DC. Dopamine transporter mRNA in autopsy studies of chronic cocaine users Molecular Brain Research. 73: 181-185. PMID 10581411 DOI: 10.1016/S0169-328X(99)00233-8  1
1999 Izenwasser S, Staley JK, Cohn S, Mash DC. Characterization of kappa1-opioid receptor binding in human insular cortex. Life Sciences. 65: 857-62. PMID 10465345 DOI: 10.1016/S0024-3205(99)00315-X  1
1999 Chen L, Segal DM, Mash DC. Semi-quantitative reverse-transcriptase polymerase chain reaction: An approach for the measurement of target gene expression in human brain Brain Research Protocols. 4: 132-139. PMID 10446407 DOI: 10.1016/S1385-299X(99)00009-4  1
1999 Haracz JL, Mash DC, Sircar R. A multicomponent learning model of drug abuse. Drug taking and craving may involve separate brain circuits underlying instrumental and classical conditioning, respectively Annals of the New York Academy of Sciences. 877: 811-819. PMID 10415711 DOI: 10.1111/j.1749-6632.1999.tb09329.x  1
1999 Mash DC, Staley JK. D3 dopamine and kappa opioid receptor alterations in human brain of cocaine-overdose victims Annals of the New York Academy of Sciences. 877: 507-522. PMID 10415668 DOI: 10.1111/j.1749-6632.1999.tb09286.x  1
1999 Callaway JC, McKenna DJ, Grob CS, Brito GS, Raymon LP, Poland RE, Andrade EN, Andrade EO, Mash DC. Pharmacokinetics of Hoasca alkaloids in healthy humans. Journal of Ethnopharmacology. 65: 243-56. PMID 10404423 DOI: 10.1016/S0378-8741(98)00168-8  1
1999 Zubaran C, Shoaib M, Stolerman IP, Pablo J, Mash DC. Noribogaine generalization to the ibogaine Stimulus: Correlation with noribogaine concentration in rat brain Neuropsychopharmacology. 21: 119-126. PMID 10379526 DOI: 10.1016/S0893-133X(99)00003-2  1
1999 Ciliax BJ, Drash GW, Staley JK, Haber S, Mobley CJ, Miller GW, Mufson EJ, Mash DC, Levey AI. Immunocytochemical localization of the dopamine transporter in human brain. The Journal of Comparative Neurology. 409: 38-56. PMID 10363710 DOI: 10.1002/(SICI)1096-9861(19990621)409:1<38::AID-CNE4>3.0.CO;2-1  1
1999 Ma SY, Ciliax BJ, Stebbins G, Jaffar S, Joyce JN, Cochran EJ, Kordower JH, Mash DC, Levey AI, Mufson EJ. Dopamine transporter-immunoreactive neurons decrease with age in the human substantia nigra. The Journal of Comparative Neurology. 409: 25-37. PMID 10363709 DOI: 10.1002/(SICI)1096-9861(19990621)409:1<25::AID-CNE3>3.0.CO;2-E  1
1999 Miller GW, Erickson JD, Perez JT, Penland SN, Mash DC, Rye DB, Levey AI. Immunochemical analysis of vesicular monoamine transporter (VMAT2) protein in Parkinson's disease. Experimental Neurology. 156: 138-48. PMID 10192785 DOI: 10.1006/exnr.1998.7008  1
1999 Basile DV, Punch MS, Pablo J, Brenner B, Hearn WL, Mash DC. Indole alkaloids from tissue-cultured Tabernanthe iboga H. Bn Natural Product Letters. 13: 233-238.  1
1998 Mufson EJ, Kahl U, Bowser R, Mash DC, Kordower JH, Deecher DC. Galanin expression within the basal forebrain in Alzheimer's disease. Comments on therapeutic potential. Annals of the New York Academy of Sciences. 863: 291-304. PMID 9928179 DOI: 10.1111/j.1749-6632.1998.tb10703.x  1
1998 Hulette CM, Welsh-Bohmer KA, Murray MG, Saunders AM, Mash DC, McIntyre LM. Neuropathological and neuropsychological changes in "normal" aging: evidence for preclinical Alzheimer disease in cognitively normal individuals. Journal of Neuropathology and Experimental Neurology. 57: 1168-74. PMID 9862640  1
1998 Efange SMN, Mash DC, Khare AB, Ouyang Q. Modified ibogaine fragments: Synthesis and preliminary pharmacological characterization of 3-ethyl-5-phenyl-1,2,3,4,5,6-hexahydroazepino[4,5- b]benzothiophenes Journal of Medicinal Chemistry. 41: 4486-4491. PMID 9804688 DOI: 10.1021/jm980156y  1
1998 Obach RS, Pablo J, Mash DC. Cytochrome P4502D6 catalyzes the O-demethylation of the psychoactive alkaloid ibogaine to 12-hydroxyibogamine Drug Metabolism and Disposition. 26: 764-768. PMID 9698290  1
1998 Mash DC, Kovera CA, Buck BE, Norenberg MD, Shapshak P, Hearn WL, Sanchez-Ramos J. Medication development of ibogaine as a pharmacotherapy for drug dependence. Annals of the New York Academy of Sciences. 844: 274-92. PMID 9668685 DOI: 10.1111/j.1749-6632.1998.tb08242.x  1
1998 Pablo JP, Mash DC. Noribogaine stimulates naloxone-sensitive [35S]GTPgammaS binding. Neuroreport. 9: 109-14. PMID 9592058  1
1998 Deecher DC, Mash DC, Staley JK, Mufson EJ. Characterization and localization of galanin receptors in human entorhinal cortex. Regulatory Peptides. 73: 149-59. PMID 9556077 DOI: 10.1016/S0167-0115(97)01067-7  1
1997 Staley JK, Mash DC, Parsons SM, Khare AB, Efange SMN. Pharmacological characterization of the vesamicol analogue (+)-[125I]MIBT in primate brain European Journal of Pharmacology. 338: 159-169. PMID 9455998 DOI: 10.1016/S0014-2999(97)81944-9  1
1997 Guillozet AL, Smiley JF, Mash DC, Mesulam MM. Butyrylcholinesterase in the life cycle of amyloid plaques. Annals of Neurology. 42: 909-18. PMID 9403484 DOI: 10.1002/ana.410420613  1
1997 Staley JK, Rothman RB, Rice KC, Partilla J, Mash DC. κ2 opioid receptors in limbic areas of the human brain are upregulated by cocaine in fatal overdose victims Journal of Neuroscience. 17: 8225-8233. PMID 9334398  1
1997 Efange SMN, Garland EM, Staley JK, Khare AB, Mash DC. Vesicular acetylcholine transporter density and Alzheimer's disease Neurobiology of Aging. 18: 407-413. PMID 9330972 DOI: 10.1016/S0197-4580(97)00038-9  1
1997 Mash DC. Are neuroadaptations in D3 dopamine receptors linked to the development of cocaine dependence? Molecular Psychiatry. 2: 7-8. PMID 9154209  1
1997 Mash DC. D3 receptor binding in human brain during cocaine overdose Molecular Psychiatry. 2: 5-6. PMID 9154208  1
1997 Segal DM, Moraes CT, Mash DC. Up-regulation of D3 dopamine receptor mRNA in the nucleus accumbens of human cocaine fatalities Molecular Brain Research. 45: 335-339. PMID 9149110 DOI: 10.1016/S0169-328X(97)00025-9  1
1997 Miller GW, Staley JK, Heilman CJ, Perez JT, Mash DC, Rye DB, Levey AI. Immunochemical analysis of dopamine transporter protein in Parkinson's disease. Annals of Neurology. 41: 530-9. PMID 9124811 DOI: 10.1002/ana.410410417  1
1997 Staley JK, Talbot JZ, Ciliax BJ, Miller GW, Levey AI, Kung MP, Kung HF, Mash DC. Radioligand binding and immunoautoradiographic evidence for a lack of toxicity to dopaminergic nerve terminals in human cocaine overdose victims. Brain Research. 747: 219-29. PMID 9045996 DOI: 10.1016/S0006-8993(96)01196-1  1
1997 Ruttenber AJ, Lawler-Heavner J, Yin M, Wetli CV, Hearn WL, Mash DC. Fatal excited delirium following cocaine use: Epidemiologic findings provide new evidence for mechanisms of cocaine toxicity Journal of Forensic Sciences. 42: 25-31. PMID 8988571  1
1996 Callaway JC, Raymon LP, Hearn WL, McKenna DJ, Grob CS, Brito GS, Mash DC. Quantitation of N,N-dimethyltryptamine and harmala alkaloids in human plasma after oral dosing with ayahuasca. Journal of Analytical Toxicology. 20: 492-7. PMID 8889686  1
1996 Staley JK, Ouyang Q, Pablo J, Hearn WL, Flynn DD, Rothman RB, Rice KC, Mash DC. Pharmacological screen for activities of 12-hydroxyibogamine: A primary metabolite of the indole alkaloid ibogaine Psychopharmacology. 127: 10-18. PMID 8880938  1
1996 Staley JK, Mash DC. Adaptive increase in D3 dopamine receptors in the brain reward circuits of human cocaine fatalities Journal of Neuroscience. 16: 6100-6106. PMID 8815892  1
1996 Mash DC, Staley JK, Doepel FM, Young SN, Ervin FR, Palmour RM. Altered dopamine transporter densities in alcohol-preferring vervet monkeys. Neuroreport. 7: 457-62. PMID 8730805  1
1996 Shah SM, Shapshak P, Rivers JE, Stewart RV, Weatherby NL, Xin KQ, Page JB, Chitwood DD, Mash DC, Vlahov D, McCoy CB. Detection of HIV-1 DNA in needle/syringes, paraphernalia, and washes from shooting galleries in Miami: a preliminary laboratory report. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association. 11: 301-6. PMID 8603266  1
1995 Flynn DD, Ferrari-DiLeo G, Levey AI, Mash DC. Differential alterations in muscarinic receptor subtypes in Alzheimer's disease: implications for cholinergic-based therapies. Life Sciences. 56: 869-76. PMID 10188787 DOI: 10.1016/0024-3205(95)00022-X  1
1995 Hearn WL, Pablo J, Hime GW, Mash DC. Identification and quantitation of ibogaine and an o-demethylated metabolite in brain and biological fluids using gas chromatography-mass spectrometry. Journal of Analytical Toxicology. 19: 427-34. PMID 8926737 DOI: 10.1093/jat/19.6.427  1
1995 Staley JK, Boja JW, Carroll FI, Seltzman HH, Wyrick CD, Lewin AH, Abraham P, Mash DC. Mapping dopamine transporters in the human brain with novel selective cocaine analog [125I]RTI-121 Synapse. 21: 364-372. PMID 8869167 DOI: 10.1002/syn.890210412  1
1995 Baumann MH, Mash DC, Staley JK. The serotonin agonist m-chlorophenylpiperazine (mCPP) binds to serotonin transporter sites in human brain Neuroreport. 6: 2150-2152. PMID 8595191  1
1995 Flynn DD, Ferrari-DiLeo G, Mash DC, Levey AI. Differential regulation of molecular subtypes of muscarinic receptors in Alzheimer's disease. Journal of Neurochemistry. 64: 1888-91. PMID 7891119  1
1995 Ferrari-DiLeo G, Mash DC, Flynn DD. Attenuation of muscarinic receptor-G-protein interaction in Alzheimer disease Molecular and Chemical Neuropathology. 24: 69-91. PMID 7755848 DOI: 10.1007/BF03160113  1
1995 Mash DC, Staley JK, Pablo JP, Holohean AM, Hackman JC, Davidoff RA. Properties of ibogaine and its principal metabolite (12-hydroxyibogamine) at the MK-801 binding site of the NMDA receptor complex. Neuroscience Letters. 192: 53-6. PMID 7675310 DOI: 10.1016/0304-3940(95)11608-Y  1
1995 Mash DC, Staley JK, Baumann MH, Rothman RB, Lee Hearn W. Identification of a primary metabolite of ibogaine that targets serotonin transporters and elevates serotonin Life Sciences. 57. PMID 7596224 DOI: 10.1016/0024-3205(95)00273-9  1
1994 Staley JK, Basile M, Flynn DD, Mash DC. Visualizing dopamine and serotonin transporters in the human brain with the potent cocaine analogue [125I]RTI-55: In vitro binding and autoradiographic characterization Journal of Neurochemistry. 62: 549-556. PMID 8294917  1
1994 Shapshak P, McCoy CB, Shah SM, Page JB, Rivers JE, Weatherby NL, Chitwood DD, Mash DC. Preliminary laboratory studies of inactivation of HIV-1 in needles and syringes containing infected blood using undiluted household bleach. Journal of Acquired Immune Deficiency Syndromes. 7: 754-9. PMID 8207659  1
1994 Staley JK, Hearn WL, Ruttenber AJ, Wetli CV, Mash DC. High affinity cocaine recognition sites on the dopamine transporter are elevated in fatal cocaine overdose victims Journal of Pharmacology and Experimental Therapeutics. 271: 1678-1685. PMID 7996484  1
1994 Zabetian CP, Staley JK, Flynn DD, Mash DC. [3H]-(+)-pentazocine binding to sigma recognition sites in human cerebellum Life Sciences. 55: PL389-PL395. PMID 7968220 DOI: 10.1016/0024-3205(94)00322-X  1
1994 Chakko S, Sepulveda S, Kessler KM, Sotomayor MC, Mash DC, Prineas RJ, Myerburg RJ. Frequency and type of electrocardiographic abnormalities in cocaine abusers (electrocardiogram in cocaine abuse) The American Journal of Cardiology. 74: 710-713. PMID 7942531 DOI: 10.1016/0002-9149(94)90315-8  1
1994 Baghdoyan HA, Mallios VJ, Duckrow RB, Mash DC. Localization of muscarinic receptor subtypes in brain stem areas regulating sleep Neuroreport. 5: 1631-1634. PMID 7819535  1
1994 Ferrari-Dileo G, Waelbroeck M, Mash DC, Flynn DD. Selective labeling and localization of the M4 (m4) muscarinic receptor subtype Molecular Pharmacology. 46: 1028-1035. PMID 7808421  1
1993 Shapshak P, McCoy CB, Rivers JE, Chitwood DD, Mash DC, Weatherby NL, Inciardi JA, Shah SM, Brown BS. Inactivation of human immunodeficiency virus-1 at short time intervals using undiluted bleach. Journal of Acquired Immune Deficiency Syndromes. 6: 218-9. PMID 8433288  1
1993 Mash DC, Sanchez-Ramos J, Weiner WJ. Transferrin receptor regulation in Parkinson's disease and MPTP-treated mice Advances in Neurology. 60: 133-139. PMID 8420130  1
1993 Emre M, Heckers S, Mash DC, Geula C, Mesulam MM. Cholinergic innervation of the amygdaloid complex in the human brain and its alterations in old age and Alzheimer's disease. The Journal of Comparative Neurology. 336: 117-34. PMID 8254109 DOI: 10.1002/cne.903360110  1
1993 Flynn DD, Mash DC. Distinct kinetic binding properties of N-[3H]-methylscopolamine afford differential labeling and localization of M1, M2, and M3 muscarinic receptor subtypes in primate brain Synapse. 14: 283-296. PMID 8248852  1
1993 Flynn DD, Sanchez-Ramos L, Mash DC. Perinatal cocaine exposure alters sigma binding site density in the placenta Research Communications in Substances of Abuse. 14: 17-36.  1
1992 Sanchez-Ramos JR, Song S, Mash DC, Weiner WJ. 21-Aminosteroids interact with the dopamine transporter to protect against 1-methyl-4-phenylpyridinium-induced neurotoxicity Journal of Neurochemistry. 58: 328-334. PMID 1727440 DOI: 10.1111/j.1471-4159.1992.tb09314.x  1
1992 Flynn DD, Vaishnav AA, Mash DC. Interactions of cocaine with primary and secondary recognition sites on muscarinic receptors Molecular Pharmacology. 41: 736-742. PMID 1569924  1
1992 Mash DC, Zabetian CP. Sigma receptors are associated with cortical limbic areas in the primate brain Synapse. 12: 195-205. PMID 1481139 DOI: 10.1002/syn.890120304  1
1992 Mesulam MM, Hersh LB, Mash DC, Geula C. Differential cholinergic innervation within functional subdivisions of the human cerebral cortex: a choline acetyltransferase study. The Journal of Comparative Neurology. 318: 316-28. PMID 1374768 DOI: 10.1002/cne.903180308  1
1992 Wang SZ, Zhu SZ, Mash DC, El-Fakahany EE. Comparison of the concentration of messenger RNA encoding four muscarinic receptor subtypes in control and Alzheimer brains Molecular Brain Research. 16: 64-70. PMID 1334201 DOI: 10.1016/0169-328X(92)90194-G  1
1991 Flynn DD, Weinstein DA, Mash DC. Loss of high‐affinity agonist binding to M1 muscarinic receptors in Alzheimer's disease: Implications for the failure of cholinergic replacement therapies Annals of Neurology. 29: 256-262. PMID 2042942 DOI: 10.1002/ana.410290305  1
1991 Hearn WL, Flynn DD, Hime GW, Rose S, Cofino JC, Mantero-Atienza E, Wetli CV, Mash DC. Cocaethylene: a unique cocaine metabolite displays high affinity for the dopamine transporter. Journal of Neurochemistry. 56: 698-701. PMID 1988563  1
1991 Hearn WL, Rose S, Wagner J, Ciarleglio A, Mash DC. Cocaethylene is more potent than cocaine in mediating lethality. Pharmacology, Biochemistry, and Behavior. 39: 531-3. PMID 1946594 DOI: 10.1016/0091-3057(91)90222-N  1
1991 Mash DC, Pablo J, Buck BE, Sanchez-Ramos J, Weiner WJ. Distribution and number of transferrin receptors in Parkinson's disease and in MPTP-treated mice Experimental Neurology. 114: 73-81. PMID 1915737 DOI: 10.1016/0014-4886(91)90086-R  1
Show low-probability matches.